Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 87Other hematologic neoplasm 59Plasma cell 40CNS 25Head & Neck 19Genitourinary 17Sarcoma 15Gynecologic 14Gastrointestinal 14Dermatologic 13Thoracic 12Myeloid 12Breast 12Endocrine 4Other solid neoplasm 3Classical hematology 3NET 1

Conditions

Neuroendocrine Tumors 69Carcinoma, Neuroendocrine 26Pheochromocytoma 24Thyroid Cancer, Papillary 23Pituitary Neoplasms 21Thyroid Neoplasms 20Adrenocortical Carcinoma 19Paraganglioma 16Multiple Endocrine Neoplasia Type 1 14Neuroblastoma 12Adenoma, Islet Cell 11Sarcoma 10Neoplasms 10Melanoma 10Lung Neoplasms 10Adrenal Gland Neoplasms 10Small Cell Lung Carcinoma 9Carcinoid Tumor 9Adenocarcinoma, Follicular 9Neoplasm Metastasis 8Gastro-enteropancreatic neuroendocrine tumor 8Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 7Cholangiocarcinoma 7Central Nervous System Neoplasms 7Carcinoma, Medullary 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Thyroid Carcinoma, Anaplastic 6Parathyroid Neoplasms 6

Interventions

olaparib 1lutetium Lu 177 dotatate 1entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recurrence × Endocrine × 90 days × Clear all
NCT06607692 2026-04-14

LUPARPED

Fundación de investigación HM

Phase 1/2 Recruiting
25 enrolled
CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT07521670 2026-04-13

STRAP

National Cancer Centre, Singapore

Phase 2 Not yet recruiting
68 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence

NCT02650401 2026-03-25

STARTRK-NG

Hoffmann-La Roche

Phase 1/2 Active not recruiting
69 enrolled 1 FDA
CNSEndocrineGenitourinaryHead & NeckSarcoma

Thyroid Cancer, Papillary, Brain Neoplasms, Glioma, Medulloblastoma, Neoplasm Metastasis, Wilms Tumor, Neuroblastoma, Recurrence, Salivary Gland Neoplasms, Sarcoma, Sarcoma, Ewing, Central Nervous System Neoplasms, Nephroma, Mesoblastic

NCT00599092 2026-03-23

Pituitary Tumor Surveillance: Pathogenic Correlation

Cedars-Sinai Medical Center

Recruiting
1,250 enrolled
Endocrine

Pituitary Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡